HSPA5 and hepatocellular carcinoma: Exosomes derived from GRP7-siRNA-modified BMSCs can sensitize hepatocellular carcinoma cells to sorafenib, and combination of si-GRP78-modified BMSC-derived exosomes and sorafenib can suppress the growth and invasion of the hepatocellular carcinoma cells in vitro [129].